Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer

Blockade of programmed cell death 1 ligand (PD-L1) has been used to treat triple-negative breast cancer (TNBC), and various strategies are under investigation to improve the treatment response rate. Inhibition of glutamine metabolism can reduce the massive consumption of glutamine by tumor cells and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yuxia, Wang, Siqi, Li, Yang, Yuan, Chen, Zhang, Jie, Xu, Ziqing, Hu, Yongzhi, Shi, Haibin, Wang, Shouju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074360/
https://www.ncbi.nlm.nih.gov/pubmed/35524267
http://dx.doi.org/10.1186/s12951-022-01424-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074360/
https://www.ncbi.nlm.nih.gov/pubmed/35524267
http://dx.doi.org/10.1186/s12951-022-01424-7

Ejemplares similares